Rocket Pharmaceuticals Inc (RCKT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RCKT | AMGN | BMY | VRTX | GILD |
| Company | Rocket Pharmaceuticals Inc | Amgen Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 13.12 | 288.18 | 58.16 | 454.24 | 89.07 |
| High | 13.15 | 288.83 | 58.22 | 455.43 | 89.07 |
| Low | 12.66 | 284.14 | 57.47 | 445.00 | 88.07 |
| Last | 12.92 | 285.47 | 57.83 | 446.90 | 88.61 |
| Change | -0.12 | -2.40 | -0.05 | -4.33 | -0.02 |
| % Change | -0.92% | -0.83% | -0.09% | -0.96% | -0.02% |
| Volume | 150,972 | 397,712 | 1,218,535 | 183,829 | 558,351 |
| 20-Day Average Volume | 846,834 | 2,760,944 | 12,075,563 | 1,276,294 | 7,343,237 |
| Previous Close | 13.04 | 287.87 | 57.88 | 451.23 | 88.63 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 15.95 | 307.19 | 55.91 | 479.02 | 90.81 |
| 20-Day Raw Stochastic | 5.41% | 18.70% | 66.45% | 1.02% | 16.22% |
| 20-Day Relative Strength | 29.34% | 33.80% | 60.13% | 39.72% | 49.91% |
| Weighted Alpha | -53.57 | -0.25 | +25.28 | +16.45 | +22.97 |
| Today's Opinion | 100% Sell | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Previous Opinion | 100% Sell | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Last Month's Opinion | 88% Sell | 8% Buy | 88% Buy | 8% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -12.82% since 11/14/24 | -3.55% since 11/14/24 | -0.91% since 11/14/24 | -7.84% since 11/14/24 | -4.29% since 11/14/24 |
| Low | 12.62 on 11/20/24 | 275.56 on 11/19/24 | 55.82 on 11/15/24 | 445.25 on 11/21/24 | 86.08 on 11/19/24 |
| High | 14.90 on 11/15/24 | 291.50 on 11/15/24 | 58.83 on 11/20/24 | 479.93 on 11/15/24 | 91.99 on 11/15/24 |
| 1-Month | |||||
| %Chg | -26.67% since 10/21/24 | -9.89% since 10/21/24 | +11.22% since 10/21/24 | -6.71% since 10/21/24 | +2.17% since 10/21/24 |
| Low | 12.62 on 11/20/24 | 275.56 on 11/19/24 | 51.81 on 10/28/24 | 445.25 on 11/21/24 | 85.60 on 10/22/24 |
| High | 18.25 on 10/22/24 | 328.25 on 11/08/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | -35.40% since 08/21/24 | -13.29% since 08/21/24 | +19.67% since 08/21/24 | -8.25% since 08/21/24 | +17.34% since 08/21/24 |
| Low | 12.62 on 11/20/24 | 275.56 on 11/19/24 | 46.88 on 08/22/24 | 445.25 on 11/21/24 | 75.35 on 08/22/24 |
| High | 22.01 on 09/17/24 | 339.17 on 09/23/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | -42.14% since 05/21/24 | -9.35% since 05/21/24 | +37.14% since 05/21/24 | +0.91% since 05/21/24 | +31.02% since 05/21/24 |
| Low | 12.62 on 11/20/24 | 275.56 on 11/19/24 | 39.35 on 07/05/24 | 435.57 on 05/30/24 | 62.07 on 05/31/24 |
| High | 26.98 on 07/26/24 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,188,687 | 154,739,632 | 117,390,888 | 116,204,808 | 110,456,552 |
| Shares Outstanding, K | 91,157 | 537,533 | 2,028,177 | 257,529 | 1,246,266 |
| Annual Sales | 0 | 28,190,000,000 | 45,006,000,000 | 9,869,200,000 | 27,116,000,000 |
| Annual Net Income | -245,600,000 | 6,717,000,000 | 8,025,000,000 | 3,619,600,000 | 5,665,000,000 |
| Last Quarter Sales | 0 | 8,503,000,000 | 11,892,000,000 | 2,771,900,000 | 7,545,000,000 |
| Last Quarter Net Income | -66,720,000 | 2,830,000,000 | 1,211,000,000 | 1,045,400,000 | 1,253,000,000 |
| 60-Month Beta | 1.09 | 0.60 | 0.44 | 0.39 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.71 on 11/07/24 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 11/11/24 | 10/30/24 | 10/31/24 | 11/04/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.600 on 10/04/24 | N/A | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | 10/04/24 | N/A | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.57 | 49.77 | 0.00 | 19.81 |